en Hamburg, August 25, 2025 — coinIX GmbH & Co. KGaA has invested €100,000 in the DeFi project Fungi through a SAFT with token warrant, at a valuation of €7.5 million. Fungi is a fully automated DeFi agent designed to optimize stablecoin yields. The platform offers users a smart, non-custodial system that reallocates deposited capital across multiple decentralized protocols on a daily basis. Its algorithm factors in expected returns, gas fees, slippage, liquidity, and protocol risk to maximize performance.
With approximately USD 500,000 in assets under management and more than USD 100 million in cumulative transaction volume, Fungi is already showing strong traction in the market. The solution is live on the Base blockchain and continues to evolve, with plans to expand to additional blockchains and broaden its yield-generation capabilities. Each user benefits from a dedicated instance of the Fungi agent, which monitors deployed stablecoins around the clock and automatically reacts to better yield opportunities. When switching between protocols is advantageous, capital is reallocated; otherwise, it remains securely positioned. Every decision incorporates factors such as base and bonus interest rates, temporary incentives, transaction costs, liquidity, and protocol-specific risks.
Once activated, Fungi functions as a personal, programmable vault. It can move assets between Aave, Morpho, Moonwell, and Fluid, reinvest earnings, or return funds directly to the user’s wallet — all within predefined limits. Users remain in full control at all times, as Fungi only has permission to operate within authorized protocols, and this access can be revoked at any point. In addition to yield optimization, Fungi continuously monitors potential risks. If irregularities such as unusual price movements, reduced liquidity, or attack warnings arise, the agent can proactively shift assets into safer protocols, provided this is technically feasible. Looking ahead, Fungi aims to manage multiple assets simultaneously, execute cross-chain strategies, and further tailor automation to individual preferences. From a few hundred dollars to a seven-figure treasury, Fungi scales with user needs.
coinIX and Fungi
“Fungi is a prime example of how AI agents can be applied in the DeFi space. The team combines technological excellence with a clear product vision. Its growing user base and significant capital flows underscore the demand for smart, automated yield solutions,” said Moritz Schildt, Managing Director of coinIX GmbH & Co. KGaA.
For coinIX, this investment aligns with its strategy of backing scalable Web3 infrastructure projects at an early stage — projects that address real-world use cases and deliver clear technological differentiation.
About coinIX Capital GmbH
Since 2017, coinIX Capital GmbH, headquartered in Hamburg, has been at the forefront of analyzing blockchain projects and cryptocurrencies, facilitating investments in this dynamic sector. Comprising specialists with extensive experience in asset management, venture capital, and cutting-edge technology analysis, the coinIX team manages a portfolio boasting over 20 investments in blockchain startups alongside crypto assets. Shares of coinIX GmbH & Co. KGaA are listed on the free market of the Düsseldorf Stock Exchange and are also traded on the Berlin and Munich stock exchanges.
About coinIX COINVEST SCI1
Launched in June 2022, coinIX COINVEST SCI1 is an open domestic special AIF under the KAGB. As a sub-portfolio of coinIX COINVEST Investment Stock Corporation with variable capital, its assets are managed by coinIX Capital GmbH, acting as a registered capital management company. Available for subscription by professional or semi-professional investors, the fund has the flexibility to invest up to 100% of its capital in crypto assets, aiming for a diversified portfolio of digital assets actively managed through ongoing selection processes. Additional income streams are generated through staking and other blockchain-native mechanisms. With the ISIN DE000A408Q55, subscriptions to the fund are only available directly through the investment company, with private investor acquisition prohibited.